Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-042018
Filing Date
2026-04-09
Accepted
2026-04-09 16:30:28
Documents
3
Period of Report
2026-04-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0285515-6k_inflarx.htm 6-K 17843
2 PRESS RELEASE, DATED APRIL 9, 2026 ea028551501ex99-1.htm EX-99.1 16164
3 GRAPHIC ea028551501ex99-1_img1.jpg GRAPHIC 2954
  Complete submission text file 0001213900-26-042018.txt   39322
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 26852011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)